ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 88 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $274,000 | -36.9% | 71,512 | -0.4% | 0.28% | +5.6% |
| Q4 2019 | $434,000 | -48.0% | 71,812 | -35.0% | 0.27% | -57.2% |
| Q3 2019 | $835,000 | -37.0% | 110,451 | +12.9% | 0.62% | -41.2% |
| Q2 2019 | $1,325,000 | +35.2% | 97,789 | -45.9% | 1.06% | +49.1% |
| Q1 2019 | $980,000 | +92.2% | 180,787 | +5.3% | 0.71% | +9.1% |
| Q4 2018 | $510,000 | – | 171,687 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |